SEC filing record
Primary Source · SEC.gov
1 Data Flags

Aeris Biotechnologies, Inc.

Platform / Operating Company2022 vintageRegulation A (Tier 2)
Latest signalReg A supplementForm 253G1 · 2022-07-276 events: 3 reg a offering amended, 1 reg a supplement, 1 reg a qualifiedLast filing 2022-07-27

Filings

6

Latest

253G1 · Jul 2022

Min Invest

—

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

AltStreet Analysis

·

Generated from EDGAR primary sources

Aeris Biotechnologies, Inc. (DE) filed a Tier 2 Regulation A offering in April 2022 for $15.0M (security type not stated), with audited financials by BF Borgers CPA PC. At filing, the issuer was pre-revenue with $33K in assets, $33K cash, $50K long-term debt, and 2 full-time employees. The filing footprint includes only the initial 1-A and 253G1 (both April–July 2022); no subsequent 1-K or 1-SA reports are present in the corpus, suggesting the offering may have been withdrawn or reporting discontinued.

Regulation A Tier 2 offerings are qualified by the SEC and open to non-accredited retail investors nationwide, with no investment limits (Tier 1 imposes state-law caps). This appears to be an early-stage biotechnology operating company raising growth capital directly from the public, a common use case for Reg A+ by small-cap issuers seeking alternatives to venture capital or traditional IPOs.

Data Flags

auditorBF Borgers CPA PC (subsequently charged by SEC in 2024 for widespread audit failures)
security_typeSecurity type not stated in Part I XML
reportingNo 1-K or 1-SA filings in corpus after initial qualification (2022); possible withdrawal or delinquency
financialsPre-revenue with minimal assets ($33K) raising $15M (450× asset base)

EDGAR Filing Data

Form 1-A — Primary Source

View on SEC.gov
CIK Number0001907923
Entity NameAeris Biotechnologies, Inc.
ExemptionRegulation A (Tier 2)
Filings on Record6 (1-A April 25, 2022 to 253G1 July 27, 2022)
Latest Filing253G1 · July 27, 2022 · 0001829126-22-014684
Latest Financial Statements—
Going Concern—
Minimum Investment—

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

6

latest Jul 27, 2022

Critical / warning

0 / 0

1 watch · 5 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

1

qualified

Latest event Supplement · Jul 27, 2022

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • The dated record: 3 facts with source, effective date and capture date, viewable as AltStreet knew them on any past day
  • 6 filing events with values and deltas, latest 2022-07-27, and alerts on the next one
  • 1 offering timeline: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Auditor of Record

BF Borgers CPA PC

As named on this issuer's SEC filings · Audited · see all issuers this firm audits

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.